Calendar Phio Pharmaceuticals Corp.

Equities

PHIO

US71880W4024

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
0.682 USD -3.40% Intraday chart for Phio Pharmaceuticals Corp. +6.58% -10.26%

Chart calendar Phio Pharmaceuticals Corp.

a1d402c56f21d23b7b14a1049ae48.HNqfQD5Xi3VbANbxPLjCtTzZkZEHEhe-eU2GwsTpIG0.WKmrDkoRzwFocZ61aomEzQWJwuhqXDqLNwDEuoKdEV8vja4OWW_ELGtFsQ~4ed7f5b5c3d5f4a65be5fe9e8b34c9a9

Upcoming events on Phio Pharmaceuticals Corp.

2024-05-08 12:00 pm American Society of Gene & Cell Therapy Meeting - Abstract Number:774
2024-05-08 Q1 2024 Earnings Release (Projected)
2024-05-16 05:30 pm Society for Investigative Dermatology Meeting - Abstract No: 283
2024-05-16 05:30 pm Society for Investigative Dermatology Meeting - Abstract No: 576
2024-05-16 05:30 pm Society for Investigative Dermatology Meeting - Abstract No: 575
2024-08-07 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-18 Q4 2024 Earnings Release (Projected)

Past events on Phio Pharmaceuticals Corp.

2024-04-02 07:30 am Q4 2023 Earnings Release
2024-03-22 01:00 pm Immunotherapy of Cancer Conference
2024-03-21 01:00 pm Immunotherapy of Cancer Conference
2024-03-21 01:00 pm Immunotherapy of Cancer Conference - Poster No : P01.03
2023-11-09 04:30 pm Q3 2023 Earnings Release
2023-11-04 12:00 pm Society for Immunotherapy of Cancer Meeting - Abstract Number : 474
2023-10-14 12:30 pm AACR NCI EORTC International Conference - INTASYL™ self-delivering RNAi therapeutic targeting BRD4 e
2023-10-14 12:30 pm AACR NCI EORTC International Conference - INTASYL™ PH-894 self-delivering RNAi targeting BRD4
2023-09-11 07:00 am H.C. Wainwright Global Investment Conference
2023-08-10 04:30 pm Q2 2023 Earnings Release
2023-07-20 09:00 am Annual General Meeting
2023-05-17 03:00 pm American Society of Gene & Cell Therapy Meeting - Abstract No: 544
2023-05-11 05:00 pm Q1 2023 Earnings Release
2023-04-18 01:30 pm American Association for Cancer Research Meeting
2023-04-17 09:00 am American Association for Cancer Research Meeting - Intratumoral PH-762
2023-03-22 05:05 pm Q4 2022 Earnings Release
2023-01-25 Reverse Split: 1 of 12
2023-01-07 Dermatology Summit
2022-11-11 09:00 am Society for Immunotherapy of Cancer Meeting - Abstract #: 1402
2022-11-11 09:00 am Society for Immunotherapy of Cancer Meeting - Abstract #:788

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,02
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-8,99
-8,60
-4.5%
-8,79
-8,80
0.08%
-13,5
-14,4
6.17%
-11,5
-12,4
7.56%
-10,8
-12,0
9.8%

-13,4

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-8,91
-8,50
-4.8%
-8,79
-8,80
0.07%
-13,3
-14,2
6.43%
-11,5
-12,4
7.42%
-10,8
-12,0
9.78%

-13,4

Net income
Million USD
Released
Forecast
Spread
-8,91
-8,50
-4.8%
-8,79
-8,80
0.07%
-13,3
-14,2
6.43%
-11,5
-12,4
7.42%
-10,8
-12,0
9.78%

-13,4

EPS
USD
Released
Forecast
Spread
-232
-224
-3.37%
-23,0
-23,0
0%
-12,5
-13,3
6.31%
-10,1
-10,9
7.51%
-5,20
-6,26
16.93%

-3,56

Announcement Date26/03/2025/03/2122/03/2222/03/2301/04/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q2 2023 Q3 2023 Q4
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
12,5
-
0,00
0,00
-



0,00
0,00
-
0,00
0,00
-
EBIT
Million USD
Released
Forecast
Spread
-3,45
-4,40
21.59%
-2,64
-4,10
35.61%
-2,52
-4,10
38.51%
-3,57
9,90
-136.07%
-2,73
-3,70
26.22%



-2,78
-2,80
0.86%
-1,90
-3,10
38.74%
Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-3,45
-4,40
21.57%
-2,64
-4,10
35.56%
-2,53
-4,10
38.27%
-3,58
9,90
-136.12%
-2,73
-3,70
26.19%



-2,78
-2,80
0.71%
-1,90
-3,10
38.87%
Net income
Million USD
Released
Forecast
Spread
-3,45
-4,40
21.57%
-2,64
-4,10
35.56%
-2,53
-4,10
38.27%
-3,58
7,50
-147.68%
-2,73
-3,70
26.19%
-2,55


-2,78
-2,80
0.71%
-1,90
-3,10
38.87%
EPS
USD
Released
Forecast
Spread
-3,12
-3,84
18.75%
-2,28
-3,60
36.67%
-2,28
-3,72
38.71%
-3,12
4,32
-172.22%
-2,42
-3,24
25.31%
-1,47


-1,14
-1,43
20.28%
-0,17
-1,30
86.92%
Announcement Date22/03/2212/05/2211/08/2210/11/2222/03/2310/08/2309/11/2301/04/24

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PHIO Stock
  4. Calendar Phio Pharmaceuticals Corp.